Eupraxia Pharmaceuticals announces CFO succession

Eupraxia Pharmaceuticals (EPRX)announced that it has appointed Alex Rothwell as the Company’s new Chief Financial Officer, effective immediately. Bruce Cousins, the Company’s outgoing CFO, is retiring and will remain in a consultant role in the near-term to ensure an orderly transition of the CFO responsibilities.